{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:52:06Z","timestamp":1781790726202,"version":"3.54.5"},"reference-count":235,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-026-00855-3","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:47:26Z","timestamp":1781531246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The potential role of the gut microbiota in the development of autoantibodies associated with Spondyloarthritis: a narrative review"],"prefix":"10.1186","volume":"27","author":[{"given":"Alaa","family":"Elsaghir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al-Hassan Soliman","family":"Wadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"855_CR1","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3390\/IJMS18040830","volume":"18","author":"S Moz","year":"2017","unstructured":"Moz S, Aita A, Basso D, Ramonda R, Plebani M, Punzi L. Spondyloarthritis: matrix metalloproteinasesas biomarkers of pathogenesis and response to tumor necrosis factor (TNF) inhibitors. Int J Mol Sci. 2017;18:830. https:\/\/doi.org\/10.3390\/IJMS18040830.","journal-title":"Int J Mol Sci"},{"key":"855_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.pop.2018.02.005","volume":"45","author":"AS Duba","year":"2018","unstructured":"Duba AS, Mathew SD. The seronegative spondyloarthropathies. Prim Care Clin Off Pract. 2018;45:271\u201387.","journal-title":"Prim Care Clin Off Pract"},{"key":"855_CR3","first-page":"1","volume":"36","author":"R Terenzi","year":"2018","unstructured":"Terenzi R, Monti S, Tesei G, Carli L. One year in review 2017: spondyloarthritis. Clin Exp Rheumatol. 2018;36:1\u201314.","journal-title":"Clin Exp Rheumatol"},{"key":"855_CR4","doi-asserted-by":"crossref","unstructured":"Rudwaleit M vd, van der Heijde D, Landew\u00e9 R, Akkoc N, Brandt J, Chou CT, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011;70:25\u201331.","DOI":"10.1136\/ard.2010.133645"},{"key":"855_CR5","doi-asserted-by":"crossref","unstructured":"Magrey MN, Danve AS, Ermann J, Walsh JA. Recognizing axial spondyloarthritis: a guide for primary care. In: Mayo Clinic Proceedings. Elsevier; 2020. p. 2499\u2013508.","DOI":"10.1016\/j.mayocp.2020.02.007"},{"issue":"Suppl 2","key":"855_CR6","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, et al. The Assessment of SpondyloArthritis International Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68(Suppl 2):ii1-44.","journal-title":"Ann Rheum Dis"},{"key":"855_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.rdc.2012.09.003","volume":"38","author":"C Stolwijk","year":"2012","unstructured":"Stolwijk C, Boonen A, van Tubergen A, Reveille JD. Epidemiology of spondyloarthritis. Rheum Dis Clin North Am. 2012;38:441\u201376. https:\/\/doi.org\/10.1016\/j.rdc.2012.09.003.","journal-title":"Rheum Dis Clin North Am"},{"key":"855_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","volume":"390","author":"J Sieper","year":"2017","unstructured":"Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390:73\u201384.","journal-title":"Lancet"},{"key":"855_CR9","doi-asserted-by":"publisher","unstructured":"Ritchlin C, Adamopoulos IE. Axial spondyloarthritis: new advances in diagnosis and management. BMJ. 2021;372:m4447. https:\/\/doi.org\/10.1136\/bmj.m4447.","DOI":"10.1136\/bmj.m4447"},{"key":"855_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41584-020-00552-4","volume":"17","author":"PC Robinson","year":"2021","unstructured":"Robinson PC, van der Linden S, Khan MA, Taylor WJ. Axial spondyloarthritis: concept, construct, classification and implications for therapy. Nat Rev Rheumatol. 2021;17:109\u201318. https:\/\/doi.org\/10.1038\/s41584-020-00552-4.","journal-title":"Nat Rev Rheumatol"},{"key":"855_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41584-022-00761-z","volume":"18","author":"A Danve","year":"2022","unstructured":"Danve A, Deodhar A. Treatment of axial spondyloarthritis: an update. Nat Rev Rheumatol. 2022;18:205\u201316.","journal-title":"Nat Rev Rheumatol"},{"key":"855_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/1744666X.2018.1477591","volume":"14","author":"M Protopopov","year":"2018","unstructured":"Protopopov M, Poddubnyy D. Radiographic progression in non-radiographic axial spondyloarthritis. Expert Rev Clin Immunol. 2018;14:525\u201333.","journal-title":"Expert Rev Clin Immunol"},{"key":"855_CR13","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/art.20990","volume":"52","author":"M Rudwaleit","year":"2005","unstructured":"Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early Ankylosing Spondylitis: do we need new criteria? Arthritis Rheum. 2005;52:1000\u20138. https:\/\/doi.org\/10.1002\/art.20990.","journal-title":"Arthritis Rheum"},{"key":"855_CR14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ARD.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Van Der Heijde D, Landew\u00e9 R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (Part II): validation and final selection. Ann Rheum Dis. 2009;68:777\u201383. https:\/\/doi.org\/10.1136\/ARD.2009.108233.","journal-title":"Ann Rheum Dis"},{"key":"855_CR15","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","volume":"377","author":"M Dougados","year":"2011","unstructured":"Dougados M, Baeten D. Spondyloarthritis. Lancet. 2011;377:2127\u201337. https:\/\/doi.org\/10.1016\/S0140-6736(11)60071-8.","journal-title":"Lancet"},{"key":"855_CR16","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1136\/ARD.2003.011882","volume":"63","author":"A Mart\u00ednez","year":"2004","unstructured":"Mart\u00ednez A, Pacheco-Tena C, V\u00e1zquez-Mellado J, Burgos-Vargas R. Relationship between disease activity and infection in patients with spondyloarthropathies. Ann Rheum Dis. 2004;63:1338\u201340. https:\/\/doi.org\/10.1136\/ARD.2003.011882.","journal-title":"Ann Rheum Dis"},{"key":"855_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.00005","volume":"10","author":"Y Liu","year":"2019","unstructured":"Liu Y, Liao X, Shi G. Autoantibodies in spondyloarthritis, focusing on anti-CD74 antibodies. Front Immunol. 2019;10:1\u20137. https:\/\/doi.org\/10.3389\/fimmu.2019.00005.","journal-title":"Front Immunol"},{"key":"855_CR18","doi-asserted-by":"publisher","unstructured":"Gill T, Asquith M, Rosenbaum JT, Colbert RA. The intestinal microbiome in spondyloarthritis. Curr Opin Rheumatol. 2015;27:319\u201325. https:\/\/doi.org\/10.1097\/BOR.0000000000000187.","DOI":"10.1097\/BOR.0000000000000187"},{"key":"855_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/mi.2010.3","volume":"3","author":"II Ivanov","year":"2010","unstructured":"Ivanov II, Littman DR. Segmented filamentous bacteria take the stage. Mucosal Immunol. 2010;3:209\u201312.","journal-title":"Mucosal Immunol"},{"key":"855_CR20","doi-asserted-by":"publisher","unstructured":"Di Jiang C, Raine T. IBD considerations in spondyloarthritis. 2020;12. https:\/\/doi.org\/10.1177\/1759720X20939410.","DOI":"10.1177\/1759720X20939410"},{"key":"855_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/annrheumdis-2019-216134","volume":"79","author":"JK Wallman","year":"2020","unstructured":"Wallman JK, Mogard E, Marsal J, Andr\u00e9asson K, J\u00f6ud A, Geijer M, et al. Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity? Ann Rheum Dis. 2020;79:159\u201361.","journal-title":"Ann Rheum Dis"},{"key":"855_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0016-5085(89)91557-6","volume":"96","author":"M De Vos","year":"1989","unstructured":"De Vos M, Cuvelier C, Mielants H, Veys E, Barbier F, Elewaut A. Ileocolonoscopy in seronegative spondylarthropathy. Gastroenterology. 1989;96:339\u201344. https:\/\/doi.org\/10.1016\/0016-5085(89)91557-6.","journal-title":"Gastroenterology"},{"key":"855_CR23","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00045.2009","author":"I Sekirov","year":"2010","unstructured":"Sekirov I, Russell SL, Antunes LCM, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010. https:\/\/doi.org\/10.1152\/physrev.00045.2009.","journal-title":"Physiol Rev"},{"key":"855_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/J.TREE.2016.03.006","volume":"31","author":"M Shapira","year":"2016","unstructured":"Shapira M. Gut microbiotas and host evolution: scaling up symbiosis. Trends Ecol Evol. 2016;31:539\u201349. https:\/\/doi.org\/10.1016\/J.TREE.2016.03.006.","journal-title":"Trends Ecol Evol"},{"key":"855_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.cell.2015.08.058","volume":"163","author":"K Atarashi","year":"2015","unstructured":"Atarashi K, Tanoue T, Ando M, Kamada N, Nagano Y, Narushima S, et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell. 2015;163:367\u201380.","journal-title":"Cell"},{"key":"855_CR26","doi-asserted-by":"publisher","first-page":"1277102","DOI":"10.3389\/fimmu.2023.1277102","volume":"14","author":"Y Fu","year":"2023","unstructured":"Fu Y, Lyu J, Wang S. The role of intestinal microbes on intestinal barrier function and host immunity from a metabolite perspective. Front Immunol. 2023;14:1277102.","journal-title":"Front Immunol"},{"key":"855_CR27","doi-asserted-by":"publisher","first-page":"103114","DOI":"10.1016\/j.jaut.2023.103114","volume":"141","author":"T Shao","year":"2023","unstructured":"Shao T, Hsu R, Rafizadeh DL, Wang L, Bowlus CL, Kumar N, et al. The gut ecosystem and immune tolerance. J Autoimmun. 2023;141:103114.","journal-title":"J Autoimmun"},{"key":"855_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-immunol-070119-115104","volume":"38","author":"H Kayama","year":"2020","unstructured":"Kayama H, Okumura R, Takeda K. Interaction between the microbiota, epithelia, and immune cells in the intestine. Annu Rev Immunol. 2020;38:23\u201348.","journal-title":"Annu Rev Immunol"},{"key":"855_CR29","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3390\/microorganisms8101587","volume":"8","author":"JY Yoo","year":"2020","unstructured":"Yoo JY, Groer M, Dutra SVO, Sarkar A, McSkimming DI. Gut microbiota and immune system interactions. Microorganisms. 2020;8:1587.","journal-title":"Microorganisms"},{"key":"855_CR30","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S0140-6736(03)12489-0","volume":"361","author":"F Guarner","year":"2003","unstructured":"Guarner F, Malagelada JR. Gut flora in health and disease. The Lancet. 2003;361:512\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(03)12489-0.","journal-title":"The Lancet"},{"key":"855_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/PRD.12352","volume":"85","author":"PI Diaz","year":"2021","unstructured":"Diaz PI. Subgingival fungi, archaea, and viruses under the omics loupe. Periodontol 2000. 2021;85:82\u20139. https:\/\/doi.org\/10.1111\/PRD.12352.","journal-title":"Periodontol 2000"},{"key":"855_CR32","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s10482-020-01474-7","volume":"113","author":"EZ Gomaa","year":"2020","unstructured":"Gomaa EZ. Human gut microbiota\/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek. 2020;113:2019\u201340. https:\/\/doi.org\/10.1007\/s10482-020-01474-7.","journal-title":"Antonie Van Leeuwenhoek"},{"key":"855_CR33","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/SJ.EMBOR.7400731\/ASSET\/CAB2B585-976E-45A9-BAE1-6D2CBE5717D1\/ASSETS\/GRAPHIC\/EMBR7400731-GRA-0001-M.JPG","volume":"7","author":"AM O\u2019Hara","year":"2006","unstructured":"O\u2019Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006;7:688\u201393. https:\/\/doi.org\/10.1038\/SJ.EMBOR.7400731\/ASSET\/CAB2B585-976E-45A9-BAE1-6D2CBE5717D1\/ASSETS\/GRAPHIC\/EMBR7400731-GRA-0001-M.JPG.","journal-title":"EMBO Rep"},{"key":"855_CR34","doi-asserted-by":"publisher","unstructured":"Mangalam AK, Yadav M, Yadav R. The emerging world of microbiome in autoimmune disorders: opportunities and challenges. Indian J Rheumatol. 2021;16:57\u201372.\u00a0https:\/\/doi.org\/10.4103\/INJR.INJR_210_20.","DOI":"10.4103\/INJR.INJR_210_20"},{"key":"855_CR35","doi-asserted-by":"publisher","first-page":"12800","DOI":"10.3390\/cimb46110762","volume":"46","author":"E-D P\u0103s\u0103ran","year":"2024","unstructured":"P\u0103s\u0103ran E-D, Diaconu AE, Oancea C, B\u0103l\u0103nescu A-R, Aurelian SM, Homentcovschi C. An actual insight into the pathogenic pathways of Ankylosing Spondylitis. Curr Issues Mol Biol. 2024;46:12800\u201312.","journal-title":"Curr Issues Mol Biol"},{"key":"855_CR36","first-page":"1097","volume":"42","author":"G Cafaro","year":"2024","unstructured":"Cafaro G, Cruciani G, Bruno L, Dal Pozzolo R, Colangelo A, Tromby F, et al. Microbiota and arthritis: cause or consequence. Clin Exp Rheumatol. 2024;42:1097\u2013103.","journal-title":"Clin Exp Rheumatol"},{"key":"855_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/eci.12100","volume":"43","author":"JJ Goedert","year":"2013","unstructured":"Goedert JJ. The microbiota and human health: beyond exploration. Eur J Clin Invest. 2013;43:10\u20131111.","journal-title":"Eur J Clin Invest"},{"key":"855_CR38","doi-asserted-by":"crossref","unstructured":"Yasuda K, Takeuchi Y, Hirota K. The pathogenicity of Th17 cells in autoimmune diseases. In: Seminars in immunopathology. Springer; 2019. p. 283\u201397.","DOI":"10.1007\/s00281-019-00733-8"},{"key":"855_CR39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.autrev.2018.08.006","volume":"18","author":"S Dolff","year":"2019","unstructured":"Dolff S, Witzke O, Wilde B. Th17 cells in renal inflammation and autoimmunity. Autoimmun Rev. 2019;18:129\u201336.","journal-title":"Autoimmun Rev"},{"key":"855_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/cei.12670","volume":"183","author":"H Jethwa","year":"2016","unstructured":"Jethwa H, Bowness P. The interleukin (IL)-23\/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment. Clin Exp Immunol. 2016;183:30\u20136.","journal-title":"Clin Exp Immunol"},{"key":"855_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.coi.2016.09.001","volume":"43","author":"A Su\u00e1rez-Fueyo","year":"2016","unstructured":"Su\u00e1rez-Fueyo A, Bradley SJ, Tsokos GC. T cells in systemic lupus erythematosus. Curr Opin Immunol. 2016;43:32\u20138.","journal-title":"Curr Opin Immunol"},{"key":"855_CR42","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.immuni.2015.12.003","volume":"43","author":"DD Patel","year":"2015","unstructured":"Patel DD, Kuchroo VK. Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions. Immunity. 2015;43:1040\u201351.","journal-title":"Immunity"},{"key":"855_CR43","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s10620-019-05777-2","volume":"65","author":"D Hollander","year":"2020","unstructured":"Hollander D, Kaunitz JD. The \u201cleaky gut\u201d: tight junctions but loose associations? Dig Dis Sci. 2020;65:1277\u201387.","journal-title":"Dig Dis Sci"},{"key":"855_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cyto.2014.11.020","volume":"74","author":"B Astry","year":"2015","unstructured":"Astry B, Venkatesha SH, Moudgil KD. Involvement of the IL-23\/IL-17 axis and the Th17\/Treg balance in the pathogenesis and control of autoimmune arthritis. Cytokine. 2015;74:54\u201361.","journal-title":"Cytokine"},{"key":"855_CR45","first-page":"651503","volume":"2014","author":"JF Zambrano-Zaragoza","year":"2014","unstructured":"Zambrano-Zaragoza JF, Romo-Mart\u00ednez EJ, Dur\u00e1n-Avelar MDJ, Garc\u00eda-Magallanes N, Vibanco-P\u00e9rez N. Th17 cells in autoimmune and infectious diseases. Int J Inflam. 2014;2014:651503.","journal-title":"Int J Inflam"},{"key":"855_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jns.2013.03.002","volume":"333","author":"A Rostami","year":"2013","unstructured":"Rostami A, Ciric B. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination. J Neurol Sci. 2013;333:76\u201387.","journal-title":"J Neurol Sci"},{"key":"855_CR47","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jaut.2008.04.017","volume":"31","author":"V Dardalhon","year":"2008","unstructured":"Dardalhon V, Korn T, Kuchroo VK, Anderson AC. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun. 2008;31:252\u20136.","journal-title":"J Autoimmun"},{"key":"855_CR48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature18848","volume":"535","author":"K Honda","year":"2016","unstructured":"Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature. 2016;535:75\u201384.","journal-title":"Nature"},{"key":"855_CR49","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3389\/fimmu.2019.00426","volume":"10","author":"P Pandiyan","year":"2019","unstructured":"Pandiyan P, Bhaskaran N, Zou M, Schneider E, Jayaraman S, Huehn J. Microbiome dependent regulation of Tregs and Th17 cells in mucosa. Front Immunol. 2019;10:426.","journal-title":"Front Immunol"},{"key":"855_CR50","doi-asserted-by":"publisher","first-page":"973563","DOI":"10.3389\/fcimb.2022.973563","volume":"12","author":"X Lyu","year":"2022","unstructured":"Lyu X, Chen J, Gao X, Yang J. Emerging story of gut dysbiosis in spondyloarthropathy: from gastrointestinal inflammation to spondyloarthritis. Front Cell Infect Microbiol. 2022;12:973563. https:\/\/doi.org\/10.3389\/fcimb.2022.973563.","journal-title":"Front Cell Infect Microbiol"},{"key":"855_CR51","doi-asserted-by":"publisher","unstructured":"Sano T, Kageyama T, Fang V, Kedmi R, Martinez CS, Talbot J, Chen A, Cabrera I, Gorshko O, Kurakake R, Yang Y, et al. Redundant cytokine requirement for intestinal microbiota-induced Th17 cell differentiation in draining lymph nodes. Cell Rep. 2021;36(8):109589. https:\/\/doi.org\/10.1016\/j.celrep.2021.109589.","DOI":"10.1016\/j.celrep.2021.109589"},{"key":"855_CR52","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.3389\/fimmu.2019.02750","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yin Y, Chen X, Zhao Y, Wu Y, Li Y, et al. Induction of intestinal Th17 cells by flagellins from segmented filamentous bacteria. Front Immunol. 2019;10:2750.","journal-title":"Front Immunol"},{"key":"855_CR53","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/imm.12950","volume":"154","author":"KL Flannigan","year":"2018","unstructured":"Flannigan KL, Denning TL. Segmented filamentous bacteria-induced immune responses: a balancing act between host protection and autoimmunity. Immunology. 2018;154:537\u201346.","journal-title":"Immunology"},{"key":"855_CR54","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.4049\/jimmunol.0900747","volume":"183","author":"J Ochoa-Rep\u00e1raz","year":"2009","unstructured":"Ochoa-Rep\u00e1raz J, Mielcarz DW, Ditrio LE, Burroughs AR, Foureau DM, Haque-Begum S, et al. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol. 2009;183:6041\u201350.","journal-title":"J Immunol"},{"key":"855_CR55","doi-asserted-by":"publisher","first-page":"618581","DOI":"10.3389\/fimmu.2021.618581","volume":"12","author":"M Mandour","year":"2021","unstructured":"Mandour M, Chen S, van de Sande MGH. The role of the IL-23\/IL-17 axis in disease initiation in spondyloarthritis: lessons learned from animal models. Front Immunol. 2021;12:618581.","journal-title":"Front Immunol"},{"key":"855_CR56","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.3390\/ijms21176401","volume":"21","author":"H Tsukazaki","year":"2020","unstructured":"Tsukazaki H, Kaito T. The role of the IL-23\/IL-17 pathway in the pathogenesis of spondyloarthritis. Int J Mol Sci. 2020;21:6401.","journal-title":"Int J Mol Sci"},{"key":"855_CR57","doi-asserted-by":"publisher","first-page":"16955","DOI":"10.1073\/pnas.1902623116","volume":"116","author":"K Tengvall","year":"2019","unstructured":"Tengvall K, Huang J, Hellstr\u00f6m C, Kammer P, Bistr\u00f6m M, Ayoglu B, et al. Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk. Proc Natl Acad Sci. 2019;116:16955\u201360.","journal-title":"Proc Natl Acad Sci"},{"key":"855_CR58","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jneuroim.2017.07.013","volume":"310","author":"JW Lindsey","year":"2017","unstructured":"Lindsey JW. Antibodies to the Epstein-Barr virus proteins BFRF3 and BRRF2 cross-react with human proteins. J Neuroimmunol. 2017;310:131\u20134.","journal-title":"J Neuroimmunol"},{"key":"855_CR59","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1096\/fj.11-190769","volume":"25","author":"AG Gabibov","year":"2011","unstructured":"Gabibov AG, Belogurov AA Jr, Lomakin YA, Zakharova MY, Avakyan ME, Dubrovskaya VV, et al. Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen. FASEB J. 2011;25:4211\u201321.","journal-title":"FASEB J"},{"key":"855_CR60","first-page":"121","volume":"22","author":"RJ Morecraft","year":"1988","unstructured":"Morecraft RJ, Blair WF, Maynard JA. Suture extrusion in small arteries and veins. Scand J Plast Reconstr Surg. 1988;22:121\u20136.","journal-title":"Scand J Plast Reconstr Surg"},{"key":"855_CR61","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/ni835","volume":"3","author":"HLE Lang","year":"2002","unstructured":"Lang HLE, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol. 2002;3:940\u20133.","journal-title":"Nat Immunol"},{"key":"855_CR62","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0002-9343(88)90385-3","volume":"85","author":"PL Schwimmbeck","year":"1988","unstructured":"Schwimmbeck PL, Oldstone MBA. Molecular mimicry between human leukocyte antigen B27 and Klebsiella: consequences for spondyloarthropathies. Am J Med. 1988;85:51\u20133.","journal-title":"Am J Med"},{"key":"855_CR63","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S1357-4310(98)01375-6","volume":"4","author":"C L\u00f3pez-Larrea","year":"1998","unstructured":"L\u00f3pez-Larrea C, Gonz\u00e1lez S, Mart\u0131\u0301nez-Borra J. The role of HLA-B27 polymorphism and molecular mimicry in spondylarthropathy. Mol Med Today. 1998;4:540\u20139.","journal-title":"Mol Med Today"},{"key":"855_CR64","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1136\/annrheumdis-2021-eular.3254","volume":"80","author":"S Hecquet","year":"2021","unstructured":"Hecquet S, Totoson P, Martin H, Prati C, Wendling D, Demougeot C, et al. AB0073 Intestinal Permeability in Spondyloarthritis: A Systematic Review of the Literature. Ann Rheum Dis. 2021;80:1067.","journal-title":"Ann Rheum Dis"},{"key":"855_CR65","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/annrheumdis-2016-210000","volume":"76","author":"F Ciccia","year":"2017","unstructured":"Ciccia F, Guggino G, Rizzo A, Alessandro R, Luchetti MM, Milling S, et al. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis. Ann Rheum Dis. 2017;76:1123\u201332.","journal-title":"Ann Rheum Dis"},{"key":"855_CR66","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/gut.52.3.370","volume":"52","author":"LA Dieleman","year":"2003","unstructured":"Dieleman LA, Goerres MS, Arends A, Sprengers D, Torrice C, Hoentjen F, et al. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut. 2003;52:370\u20136.","journal-title":"Gut"},{"issue":"350","key":"855_CR67","first-page":"830","volume":"2015","author":"I Spadoni","year":"1979","unstructured":"Spadoni I, Zagato E, Bertocchi A, Paolinelli R, Hot E, Di Sabatino A, et al. A gut-vascular barrier controls the systemic dissemination of bacteria. Science. 1979;2015(350):830\u20134.","journal-title":"Science"},{"key":"855_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc8959","volume":"14","author":"OY Kim","year":"2010","unstructured":"Kim OY, Monsel A, Bertrand M, Coriat P, Cavaillon J-M, Adib-Conquy M. Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammation. Crit Care. 2010;14:1\u201312.","journal-title":"Crit Care"},{"key":"855_CR69","doi-asserted-by":"publisher","first-page":"e105684","DOI":"10.1371\/journal.pone.0105684","volume":"9","author":"P Lin","year":"2014","unstructured":"Lin P, Bach M, Asquith M, Lee AY, Akileswaran L, Stauffer P, et al. HLA-B27 and human \u03b22-microglobulin affect the gut microbiota of transgenic rats. PLoS ONE. 2014;9:e105684.","journal-title":"PLoS ONE"},{"key":"855_CR70","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/cei.12818","volume":"185","author":"A Shukla","year":"2016","unstructured":"Shukla A, Gaur P, Aggarwal A. Effect of probiotics on clinical and immune parameters in enthesitis-related arthritis category of juvenile idiopathic arthritis. Clin Exp Immunol. 2016;185:301\u20138.","journal-title":"Clin Exp Immunol"},{"key":"855_CR71","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/BOR.0000000000001079","volume":"37","author":"VR Rodriguez","year":"2025","unstructured":"Rodriguez VR, Essex M, Poddubnyy D. The gut microbiota in spondyloarthritis: an update. Curr Opin Rheumatol. 2025;37:199\u2013206.","journal-title":"Curr Opin Rheumatol"},{"key":"855_CR72","doi-asserted-by":"publisher","first-page":"105923","DOI":"10.1016\/j.jbspin.2025.105923","volume":"92","author":"D Mauro","year":"2025","unstructured":"Mauro D, Cai B, Ciancio A, Forte G, Gandolfo S, Thomas R, et al. The role of the gut and intestinal dysbiosis in the pathogenesis of spondyloarthritis. Jt Bone Spine. 2025;92:105923.","journal-title":"Jt Bone Spine"},{"key":"855_CR73","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/ca.24215","volume":"38","author":"S Wang","year":"2025","unstructured":"Wang S, Liu Y, Zou X, Pan M, Wan Q, Chu X. Exploring the pathogenesis of RA through the gut\u2010articular axis\u2010dysbiosis a potential factor. Clin Anat. 2025;38:134\u201345.","journal-title":"Clin Anat"},{"key":"855_CR74","doi-asserted-by":"crossref","unstructured":"Neurath MF, Artis D, Becker C. The intestinal barrier: a pivotal role in health, inflammation, and cancer. Lancet Gastroenterol Hepatol. 2025;10:573\u201392.","DOI":"10.1016\/S2468-1253(24)00390-X"},{"key":"855_CR75","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1038\/cti.2016.17","volume":"5","author":"R Corr\u00eaa\u2010Oliveira","year":"2016","unstructured":"Corr\u00eaa\u2010Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MAR. Regulation of immune cell function by short\u2010chain fatty acids. Clin Transl Immunol. 2016;5:e73.","journal-title":"Clin Transl Immunol"},{"key":"855_CR76","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","volume":"24","author":"ER Mann","year":"2024","unstructured":"Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol. 2024;24:577\u201395.","journal-title":"Nat Rev Immunol"},{"key":"855_CR77","doi-asserted-by":"publisher","first-page":"108983","DOI":"10.1016\/j.intimp.2022.108983","volume":"110","author":"SA Jasim","year":"2022","unstructured":"Jasim SA, Opulencia MJC, Ram\u00edrez-Coronel AA, Abdelbasset WK, Abed MH, Markov A, et al. The emerging role of microbiota-derived short-chain fatty acids in immunometabolism. Int Immunopharmacol. 2022;110:108983.","journal-title":"Int Immunopharmacol"},{"key":"855_CR78","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jaci.2022.11.007","volume":"151","author":"JK Tan","year":"2023","unstructured":"Tan JK, Macia L, Mackay CR. Dietary fiber and SCFAs in the regulation of mucosal immunity. J Allergy Clin Immunol. 2023;151:361\u201370.","journal-title":"J Allergy Clin Immunol"},{"key":"855_CR79","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1038\/ctg.2015.34","volume":"6","author":"K Cushing","year":"2015","unstructured":"Cushing K, Alvarado DM, Ciorba MA. Butyrate and mucosal inflammation: new scientific evidence supports clinical observation. Clin Transl Gastroenterol. 2015;6:e108.","journal-title":"Clin Transl Gastroenterol"},{"key":"855_CR80","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41423-023-00987-1","volume":"20","author":"CH Kim","year":"2023","unstructured":"Kim CH. Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity. Cell Mol Immunol. 2023;20:341\u201350.","journal-title":"Cell Mol Immunol"},{"key":"855_CR81","doi-asserted-by":"publisher","first-page":"8272","DOI":"10.3390\/ijms23158272","volume":"23","author":"C Schiweck","year":"2022","unstructured":"Schiweck C, Edwin Thanarajah S, Aichholzer M, Matura S, Reif A, Vrieze E, et al. Regulation of CD4+ and CD8+ T cell biology by short-chain fatty acids and its relevance for autoimmune pathology. Int J Mol Sci. 2022;23:8272.","journal-title":"Int J Mol Sci"},{"key":"855_CR82","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s13311-017-0588-x","volume":"15","author":"SN Freedman","year":"2018","unstructured":"Freedman SN, Shahi SK, Mangalam AK. The \u201cgut feeling\u201d: breaking down the role of gut microbiome in multiple sclerosis. Neurotherapeutics. 2018;15:109\u201325.","journal-title":"Neurotherapeutics"},{"key":"855_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-017-1175-y","volume":"15","author":"RK Singh","year":"2017","unstructured":"Singh RK, Chang H-W, Yan DI, Lee KM, Ucmak D, Wong K, et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med. 2017;15:1\u201317.","journal-title":"J Transl Med"},{"key":"855_CR84","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","volume":"23","author":"K Makki","year":"2018","unstructured":"Makki K, Deehan EC, Walter J, B\u00e4ckhed F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe. 2018;23:705\u201315. https:\/\/doi.org\/10.1016\/j.chom.2018.05.012.","journal-title":"Cell Host Microbe"},{"key":"855_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-016-0296-x","volume":"8","author":"LS Zhang","year":"2016","unstructured":"Zhang LS, Davies SS. Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med. 2016;8:1\u201318.","journal-title":"Genome Med"},{"key":"855_CR86","doi-asserted-by":"publisher","first-page":"511105","DOI":"10.3389\/fneur.2020.00150","volume":"11","author":"N Cady","year":"2020","unstructured":"Cady N, Peterson SR, Freedman SN, Mangalam AK. Beyond metabolism: the complex interplay between dietary phytoestrogens, gut bacteria, and cells of nervous and immune systems. Front Neurol. 2020;11:511105.","journal-title":"Front Neurol"},{"key":"855_CR87","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s43657-023-00095-0","volume":"3","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhong W, Li X, Shen F, Ma X, Yang Q, et al. Diets, gut microbiota and metabolites. Phenomics. 2023;3:268\u201384.","journal-title":"Phenomics"},{"key":"855_CR88","doi-asserted-by":"publisher","first-page":"1491821","DOI":"10.3389\/fnut.2024.1491821","volume":"11","author":"Q Wang","year":"2024","unstructured":"Wang Q, Huang H, Yang Y, Yang X, Li X, Zhong W, et al. Reinventing gut health: leveraging dietary bioactive compounds for the prevention and treatment of diseases. Front Nutr. 2024;11:1491821.","journal-title":"Front Nutr"},{"key":"855_CR89","doi-asserted-by":"publisher","first-page":"658354","DOI":"10.3389\/fimmu.2021.658354","volume":"12","author":"N Gasaly","year":"2021","unstructured":"Gasaly N, De Vos P, Hermoso MA. Impact of bacterial metabolites on gut barrier function and host immunity: a focus on bacterial metabolism and its relevance for intestinal inflammation. Front Immunol. 2021;12:658354.","journal-title":"Front Immunol"},{"key":"855_CR90","doi-asserted-by":"publisher","unstructured":"Furst A, Gill T. Exploring the role of gut microbes in spondyloarthritis: implications for pathogenesis and therapeutic strategies. Best Pract Res Clin Rheumatol. 2024;38(2):101961. https:\/\/doi.org\/10.1016\/j.berh.2024.101961.","DOI":"10.1016\/j.berh.2024.101961"},{"key":"855_CR91","doi-asserted-by":"publisher","first-page":"965709","DOI":"10.3389\/fmicb.2022.965709","volume":"13","author":"T Huang","year":"2022","unstructured":"Huang T, Pu Y, Wang X, Li Y, Yang H, Luo Y, et al. Metabolomic analysis in spondyloarthritis: A systematic review. Front Microbiol. 2022;13:965709.","journal-title":"Front Microbiol"},{"key":"855_CR92","first-page":"180","volume":"9","author":"SP Myers","year":"2004","unstructured":"Myers SP, Hawrelak J. The causes of intestinal dysbiosis: a review. Altern Med Rev. 2004;9:180\u201397.","journal-title":"Altern Med Rev"},{"key":"855_CR93","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/NEJMra1600266","volume":"375","author":"SV Lynch","year":"2016","unstructured":"Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375:2369\u201379.","journal-title":"N Engl J Med"},{"key":"855_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13075-016-1093-Z\/FIGURES\/3","volume":"18","author":"JJ de Winter","year":"2016","unstructured":"de Winter JJ, van Mens LJ, van der Heijde D, Landew\u00e9 R, Baeten DL. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther. 2016;18:1\u201311. https:\/\/doi.org\/10.1186\/S13075-016-1093-Z\/FIGURES\/3.","journal-title":"Arthritis Res Ther"},{"key":"855_CR95","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1002\/ART.30558","volume":"63","author":"JT Rosenbaum","year":"2011","unstructured":"Rosenbaum JT, Davey MP. Hypothesis: time for a gut check: HLA B27 predisposes to ankylosing spondylitis by altering the microbiome. Arthritis Rheumatol. 2011;63:3195. https:\/\/doi.org\/10.1002\/ART.30558.","journal-title":"Arthritis Rheumatol"},{"key":"855_CR96","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1136\/ARD.37.2.146","volume":"37","author":"RW Ebringer","year":"1978","unstructured":"Ebringer RW, Cawdell DR, Cowling P, Ebringer A. Sequential studies in ankylosing spondylitis. association of Klebsiella pneumoniae with active disease. Ann Rheum Dis. 1978;37:146\u201351. https:\/\/doi.org\/10.1136\/ARD.37.2.146.","journal-title":"Ann Rheum Dis"},{"key":"855_CR97","doi-asserted-by":"publisher","unstructured":"Zhang Y, Xie Z, Zhou J, Li Y. The altered metabolites contributed by dysbiosis of gut microbiota are associated with microbial translocation and immune activation during HIV infection. 2023:1\u201314. https:\/\/doi.org\/10.3389\/fimmu.2022.1020822.","DOI":"10.3389\/fimmu.2022.1020822"},{"key":"855_CR98","doi-asserted-by":"publisher","unstructured":"Pellicano C, Leodori G, Innocenti GP, Gigante A, Rosato E. Microbiome, autoimmune diseases and HIV infection: Friends or foes? Nutrients. 2019;11(11):2629. https:\/\/doi.org\/10.3390\/nu11112629.","DOI":"10.3390\/nu11112629"},{"key":"855_CR99","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.it.2013.07.001","volume":"34","author":"W Strober","year":"2013","unstructured":"Strober W. Impact of the gut microbiome on mucosal inflammation. Trends Immunol. 2013;34:423\u201330.","journal-title":"Trends Immunol"},{"key":"855_CR100","doi-asserted-by":"publisher","first-page":"1010572","DOI":"10.3389\/fimmu.2022.1010572","volume":"13","author":"Z-Y Song","year":"2022","unstructured":"Song Z-Y, Yuan D, Zhang S-X. Role of the microbiome and its metabolites in ankylosing spondylitis. Front Immunol. 2022;13:1010572.","journal-title":"Front Immunol"},{"key":"855_CR101","doi-asserted-by":"publisher","unstructured":"Taurog JD, Maika SD, Satumtira N, Dorris ML, McLean IL, Yanagisawa H, Sayad A, Stagg AJ, Fox GM, Le O'Brien A, Rehman M, Zhou M, Weiner AL, Splawski JB, Richardson JA, Hammer RE. Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev. 1999;169(1):209\u201323. https:\/\/doi.org\/10.1111\/j.1600-065X.1999.tb01317.x.","DOI":"10.1111\/j.1600-065X.1999.tb01317.x"},{"key":"855_CR102","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1146\/annurev-immunol-030409-101330","volume":"28","author":"DA Hill","year":"2009","unstructured":"Hill DA, Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol. 2009;28:623\u201367.","journal-title":"Annu Rev Immunol"},{"key":"855_CR103","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1084\/jem.180.6.2359","volume":"180","author":"JD Taurog","year":"1994","unstructured":"Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fern\u00e1ndez-Sueiro JL, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994;180:2359\u201364.","journal-title":"J Exp Med"},{"key":"855_CR104","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1172\/JCI118878","volume":"98","author":"HC Rath","year":"1996","unstructured":"Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE, Balish E, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27\/human beta2 microglobulin transgenic rats. J Clin Invest. 1996;98:945\u201353.","journal-title":"J Clin Invest"},{"key":"855_CR105","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.immuni.2014.03.005","volume":"40","author":"Y Goto","year":"2014","unstructured":"Goto Y, Panea C, Nakato G, Cebula A, Lee C, Diez MG, et al. Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity. 2014;40:594\u2013607.","journal-title":"Immunity"},{"key":"855_CR106","doi-asserted-by":"publisher","unstructured":"Costello ME, Ciccia F, Willner D, Warrington N, Robinson PC, Gardiner B, Marshall M, Kenna TJ, Triolo G, Brown MA. Brief report: intestinal dysbiosis in ankylosing spondylitis. Arthritis Rheumatol. 2015;67(3):686\u201391. https:\/\/doi.org\/10.1002\/art.38967.","DOI":"10.1002\/art.38967"},{"key":"855_CR107","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/ibd.21462","volume":"17","author":"NA Nagalingam","year":"2011","unstructured":"Nagalingam NA, Kao JY, Young VB. Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis. Inflamm Bowel Dis. 2011;17:917\u201326.","journal-title":"Inflamm Bowel Dis"},{"key":"855_CR108","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/rheumatology\/41.12.1395","volume":"41","author":"S Stebbings","year":"2002","unstructured":"Stebbings S, Munro K, Simon MA, Tannock G, Highton J, Harmsen H, et al. Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatology. 2002;41:1395\u2013401.","journal-title":"Rheumatology"},{"key":"855_CR109","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3899\/jrheum.080964","volume":"36","author":"SM Stebbings","year":"2009","unstructured":"Stebbings SM, Taylor C, Tannock GW, Baird MA, Highton J. The immune response to autologous Bacteroides in ankylosing spondylitis is characterized by reduced interleukin 10 production. J Rheumatol. 2009;36:797\u2013800.","journal-title":"J Rheumatol"},{"key":"855_CR110","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/01.MIB.0000183421.02316.d5","volume":"11","author":"F Hoentjen","year":"2005","unstructured":"Hoentjen F, Welling GW, Harmsen HJM, Zhang X, Snart J, Tannock GW, et al. Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm Bowel Dis. 2005;11:977\u201385.","journal-title":"Inflamm Bowel Dis"},{"key":"855_CR111","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1002\/art.20336","volume":"50","author":"MA Penttinen","year":"2004","unstructured":"Penttinen MA, Heiskanen KM, Mohapatra R, DeLay ML, Colbert RA, Sistonen L, et al. Enhanced intracellular replication of Salmonella enteritidis in HLA\u2013B27\u2013expressing human monocytic cells: dependency on glutamic acid at position 45 in the B pocket of HLA\u2013B27. Arthritis Rheumatol. 2004;50:2255\u201363.","journal-title":"Arthritis Rheumatol"},{"key":"855_CR112","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/ard.2004.028837","volume":"64","author":"D Laukens","year":"2005","unstructured":"Laukens D, Peeters H, Marichal D, Vander Cruyssen B, Mielants H, Elewaut D, et al. CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn\u2019s disease. Ann Rheum Dis. 2005;64:930\u20135.","journal-title":"Ann Rheum Dis"},{"key":"855_CR113","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3899\/jrheum.100542","volume":"38","author":"YP Singh","year":"2011","unstructured":"Singh YP, Singh AK, Aggarwal A, Misra R. Evidence of cellular immune response to outer membrane protein of Salmonellatyphimurium in patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis. J Rheumatol. 2011;38:161\u20136.","journal-title":"J Rheumatol"},{"key":"855_CR114","first-page":"1241","volume":"27","author":"R Scarpa","year":"2000","unstructured":"Scarpa R, Manguso F, D\u2019Arienzo A, D\u2019Armiento FP, Astarita C, Mazzacca G, et al. Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. J Rheumatol. 2000;27:1241\u20136.","journal-title":"J Rheumatol"},{"key":"855_CR115","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/art.38892","volume":"67","author":"JU Scher","year":"2015","unstructured":"Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 2015;67:128\u201339.","journal-title":"Arthritis Rheumatol"},{"key":"855_CR116","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1053\/j.gastro.2010.08.049","volume":"139","author":"BP Willing","year":"2010","unstructured":"Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010;139:1844\u201354.","journal-title":"Gastroenterology"},{"key":"855_CR117","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1002\/art.39724","volume":"68","author":"CE Goh","year":"2016","unstructured":"Goh CE, Kopp J, Papapanou PN, Molitor JA, Demmer RT. Association between serum antibodies to periodontal bacteria and rheumatoid factor in the Third National Health and Nutrition Examination Survey. Arthritis Rheumatol. 2016;68:2384\u201393.","journal-title":"Arthritis Rheumatol"},{"key":"855_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-016-0068-6","volume":"14","author":"L Lange","year":"2016","unstructured":"Lange L, Thiele GM, McCracken C, Wang G, Ponder LA, Angeles-Han ST, et al. Symptoms of periodontitis and antibody responses to Porphyromonas gingivalis in juvenile idiopathic arthritis. Pediatr Rheumatol. 2016;14:1\u20137.","journal-title":"Pediatr Rheumatol"},{"key":"855_CR119","first-page":"1500","volume":"35","author":"J Vaahtovuo","year":"2008","unstructured":"Vaahtovuo J, Munukka E, Korkeam\u00e4ki M, Luukkainen R, Toivanen P. Fecal microbiota in early rheumatoid arthritis. J Rheumatol. 2008;35:1500\u20135.","journal-title":"J Rheumatol"},{"key":"855_CR120","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.reuma.2014.11.001","volume":"11","author":"J Moreno","year":"2015","unstructured":"Moreno J. Prevotella copri and the microbial pathogenesis of rheumatoid arthritis. Reumatol Clin. 2015;11:61\u20133.","journal-title":"Reumatol Clin"},{"key":"855_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-016-0299-7","volume":"8","author":"J Chen","year":"2016","unstructured":"Chen J, Wright K, Davis JM, Jeraldo P, Marietta EV, Murray J, et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. 2016;8:1\u201314.","journal-title":"Genome Med"},{"key":"855_CR122","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00284-013-0338-1","volume":"67","author":"X Liu","year":"2013","unstructured":"Liu X, Zou Q, Zeng B, Fang Y, Wei H. Analysis of fecal lactobacillus community structure in patients with early rheumatoid arthritis. Curr Microbiol. 2013;67:170\u20136. https:\/\/doi.org\/10.1007\/s00284-013-0338-1.","journal-title":"Curr Microbiol"},{"key":"855_CR123","doi-asserted-by":"publisher","first-page":"e36095","DOI":"10.1371\/journal.pone.0036095","volume":"7","author":"A Gomez","year":"2012","unstructured":"Gomez A, Luckey D, Yeoman CJ, Marietta EV, Berg Miller ME, Murray JA, et al. Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible* 0401 mice but not arthritis-resistant* 0402 mice. PLoS ONE. 2012;7:e36095.","journal-title":"PLoS ONE"},{"key":"855_CR124","doi-asserted-by":"publisher","first-page":"15613","DOI":"10.1038\/s41598-017-15802-x","volume":"7","author":"R Rogier","year":"2017","unstructured":"Rogier R, Evans-Marin H, Manasson J, van der Kraan PM, Walgreen B, Helsen MM, et al. Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis. Sci Rep. 2017;7:15613.","journal-title":"Sci Rep"},{"key":"855_CR125","first-page":"90","volume":"64","author":"AC Ericsson","year":"2014","unstructured":"Ericsson AC, Hagan CE, Davis DJ, Franklin CL. Segmented filamentous bacteria: commensal microbes with potential effects on research. Comp Med. 2014;64:90\u20138.","journal-title":"Comp Med"},{"key":"855_CR126","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1136\/ard-2023-224692","volume":"82","author":"DS Pisetsky","year":"2023","unstructured":"Pisetsky DS. Annals of the Rheumatic Diseases collection on autoantibodies in the rheumatic diseases: new insights into pathogenesis and the development of novel biomarkers. Ann Rheum Dis. 2023;82:1243\u20137.","journal-title":"Ann Rheum Dis"},{"key":"855_CR127","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fimmu.2019.00005","volume":"10","author":"Y Liu","year":"2019","unstructured":"Liu Y, Liao X, Shi G. Autoantibodies in spondyloarthritis, focusing on anti-CD74 antibodies. Front Immunol. 2019;10:5.","journal-title":"Front Immunol"},{"key":"855_CR128","doi-asserted-by":"publisher","first-page":"105533","DOI":"10.1016\/j.jbspin.2023.105533","volume":"90","author":"N Ziade","year":"2023","unstructured":"Ziade N, Maroof A, Abi Najm A, Witte T, Baraliakos X. Diagnostic value of the anti-CD74 antibodies for axial spondyloarthritis: results of a prospective study in patients with suspicious low back pain. Joint Bone Spine. 2023;90:105533. https:\/\/doi.org\/10.1016\/j.jbspin.2023.105533.","journal-title":"Joint Bone Spine"},{"key":"855_CR129","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/rheumatology\/keac384","volume":"62","author":"A-S De Craemer","year":"2023","unstructured":"De Craemer A-S, Witte T, Lobaton Ortega T, Hoorens A, De Vos M, Cuvelier C, et al. Anti-CD74 IgA antibodies show diagnostic potential for axial spondyloarthritis but are not associated with microscopic gut inflammation. Rheumatology. 2023;62:984\u201390. https:\/\/doi.org\/10.1093\/rheumatology\/keac384.","journal-title":"Rheumatology"},{"key":"855_CR130","doi-asserted-by":"publisher","unstructured":"Slobodkin M, Polachek A, Furer V, Elkayam O, Gertel S. Identification of autoantibodies against PsoP27 in synovial fluid derived from psoriatic arthritis and rheumatoid arthritis patients. Scand J Clin Lab Invest. 2024;84(3):211\u20137. https:\/\/doi.org\/10.1080\/00365513.2024.2352844.","DOI":"10.1080\/00365513.2024.2352844"},{"key":"855_CR131","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S0006-2952(00)00424-X","volume":"60","author":"S Zolnierowicz","year":"2000","unstructured":"Zolnierowicz S. Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. Biochem Pharmacol. 2000;60:1225\u201335.","journal-title":"Biochem Pharmacol"},{"key":"855_CR132","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1002\/art.38763","volume":"66","author":"Y Kim","year":"2014","unstructured":"Kim Y, Sohn DH, Zhao X, Sokolove J, Lindstrom TM, Yoo B, et al. Role of protein phosphatase magnesium-dependent 1A and anti\u2013protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis. Arthritis Rheumatol. 2014;66:2793\u2013803.","journal-title":"Arthritis Rheumatol"},{"key":"855_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42358-024-00412-9","volume":"64","author":"Y-J Lee","year":"2024","unstructured":"Lee Y-J, Lee E-J, Ahn SM, Hong S, Oh JS, Lee C-K, et al. Anti-protein phosphatase magnesium-dependent 1A-IgM levels in patients with active ankylosing spondylitis: a potential biomarker. Adv Rheumatol. 2024;64:1\u20137.","journal-title":"Adv Rheumatol"},{"key":"855_CR134","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/978-1-4419-0298-6_8","volume-title":"Molecular mechanisms of spondyloarthropathies","author":"G Schett","year":"2009","unstructured":"Schett G. Bone formation versus bone resorption in ankylosing spondylitis. In: Molecular mechanisms of spondyloarthropathies. 2009. p. 114\u201321."},{"key":"855_CR135","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","volume":"19","author":"KES Poole","year":"2005","unstructured":"Poole KES, Van Bezooijen RL, Loveridge N, Hamersma H, Papapoulos SE, L\u00f6wik CW, et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J. 2005;19:1842\u20134.","journal-title":"FASEB J"},{"key":"855_CR136","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/art.23260","volume":"58","author":"J Sieper","year":"2008","unstructured":"Sieper J, Appel H, Braun J, Rudwaleit M. Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. Arthritis Rheumatol. 2008;58:649\u201356.","journal-title":"Arthritis Rheumatol"},{"key":"855_CR137","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1002\/art.24888","volume":"60","author":"H Appel","year":"2009","unstructured":"Appel H, Ruiz-Heiland G, Listing J, Zwerina J, Herrmann M, Mueller R, et al. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheumatol. 2009;60:3257\u201362.","journal-title":"Arthritis Rheumatol"},{"key":"855_CR138","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1136\/annrheumdis-2013-203630","volume":"73","author":"FWL Tsui","year":"2014","unstructured":"Tsui FWL, Tsui HW, Las Heras F, Pritzker KPH, Inman RD. Serum levels of novel noggin and sclerostin-immune complexes are elevated in ankylosing spondylitis. Ann Rheum Dis. 2014;73:1873\u20139.","journal-title":"Ann Rheum Dis"},{"key":"855_CR139","doi-asserted-by":"publisher","unstructured":"Luchetti MM, Ciccia F, Avellini C, Benfaremo D, Guggino G, Farinelli A, et al. Sclerostin and antisclerostin antibody serum levels predict the presence of axial spondyloarthritis in patients with inflammatory bowel disease. J Rheumatol. 2018;45:630\u20137.\u00a0https:\/\/doi.org\/10.3899\/jrheum.170833.","DOI":"10.3899\/jrheum.170833"},{"key":"855_CR140","doi-asserted-by":"publisher","first-page":"1156350","DOI":"10.3389\/fimmu.2023.1156350","volume":"14","author":"X Feng","year":"2023","unstructured":"Feng X, Tong W, Li J, Xu Y, Zhu S, Xu W. Diagnostic value of anti-Kaiso autoantibody in axial spondyloarthritis. Front Immunol. 2023;14:1156350.","journal-title":"Front Immunol"},{"key":"855_CR141","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bone.2017.07.002","volume":"103","author":"C Bougault","year":"2017","unstructured":"Bougault C, El Jamal A, Briolay A, Mebarek S, Boutet M-A, Garraud T, et al. Involvement of sphingosine kinase\/sphingosine 1-phosphate metabolic pathway in spondyloarthritis. Bone. 2017;103:150\u20138.","journal-title":"Bone"},{"key":"855_CR142","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1093\/nar\/gkf398","volume":"30","author":"JM Daniel","year":"2002","unstructured":"Daniel JM, Spring CM, Crawford HC, Reynolds AB, Baig A. The p120 ctn-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides. Nucleic Acids Res. 2002;30:2911\u20139.","journal-title":"Nucleic Acids Res"},{"key":"855_CR143","doi-asserted-by":"publisher","first-page":"15229","DOI":"10.1073\/pnas.1213726109","volume":"109","author":"BA Buck-Koehntop","year":"2012","unstructured":"Buck-Koehntop BA, Stanfield RL, Ekiert DC, Martinez-Yamout MA, Dyson HJ, Wilson IA, et al. Molecular basis for recognition of methylated and specific DNA sequences by the zinc finger protein Kaiso. Proc Natl Acad Sci. 2012;109:15229\u201334.","journal-title":"Proc Natl Acad Sci"},{"key":"855_CR144","doi-asserted-by":"publisher","first-page":"e74160","DOI":"10.1371\/journal.pone.0074160","volume":"8","author":"R Chaudhary","year":"2013","unstructured":"Chaudhary R, Pierre CC, Nanan K, Wojtal D, Morone S, Pinelli C, et al. The POZ-ZF transcription factor Kaiso (ZBTB33) induces inflammation and progenitor cell differentiation in the murine intestine. PLoS ONE. 2013;8:e74160.","journal-title":"PLoS ONE"},{"key":"855_CR145","doi-asserted-by":"publisher","first-page":"24538","DOI":"10.1074\/jbc.M116.746370","volume":"291","author":"A Pozner","year":"2016","unstructured":"Pozner A, Terooatea TW, Buck-Koehntop BA. Cell-specific Kaiso (ZBTB33) regulation of cell cycle through cyclin D1 and cyclin E1. J Biol Chem. 2016;291:24538\u201350.","journal-title":"J Biol Chem"},{"key":"855_CR146","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/j.ajpath.2012.08.008","volume":"181","author":"J Jones","year":"2012","unstructured":"Jones J, Wang H, Zhou J, Hardy S, Turner T, Austin D, et al. Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells. Am J Pathol. 2012;181:1836\u201346. https:\/\/doi.org\/10.1016\/j.ajpath.2012.08.008.","journal-title":"Am J Pathol"},{"key":"855_CR147","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.3074","volume":"19","author":"R Baron","year":"2013","unstructured":"Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013;19:179\u201392.","journal-title":"Nat Med"},{"key":"855_CR148","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00441-014-1891-z","volume":"357","author":"O Felthaus","year":"2014","unstructured":"Felthaus O, Gosau M, Klein S, Prantl L, Reichert TE, Schmalz G, et al. Dexamethasone-related osteogenic differentiation of dental follicle cells depends on ZBTB16 but not Runx2. Cell Tissue Res. 2014;357:695\u2013705.","journal-title":"Cell Tissue Res"},{"key":"855_CR149","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1002\/jcb.25634","volume":"117","author":"S Onizuka","year":"2016","unstructured":"Onizuka S, Iwata T, Park S, Nakai K, Yamato M, Okano T, et al. ZBTB16 as a downstream target gene of osterix regulates osteoblastogenesis of human multipotent mesenchymal stromal cells. J Cell Biochem. 2016;117:2423\u201334.","journal-title":"J Cell Biochem"},{"key":"855_CR150","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nrrheum.2009.258","volume":"6","author":"WP Maksymowych","year":"2010","unstructured":"Maksymowych WP. Disease modification in ankylosing spondylitis. Nat Rev Rheumatol. 2010;6:75\u201381.","journal-title":"Nat Rev Rheumatol"},{"key":"855_CR151","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1084\/jem.144.1.179","volume":"144","author":"ES Vitetta","year":"1976","unstructured":"Vitetta ES, Poulik MD, Klein J, Uhr JW. Beta 2-microglobulin is selectively associated with H-2 and TL alloantigens on murine lymphoid cells. J Exp Med. 1976;144:179\u201392.","journal-title":"J Exp Med"},{"key":"855_CR152","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.4049\/jimmunol.139.9.3132","volume":"139","author":"D G\u00fcssow","year":"1987","unstructured":"G\u00fcssow D, Rein R, Ginjaar I, Hochstenbach F, Seemann G, Kottman A, et al. The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit. J Immunol. 1987;139:3132\u20138.","journal-title":"J Immunol"},{"issue":"187","key":"855_CR153","first-page":"1196","volume":"1975","author":"N Talal","year":"1979","unstructured":"Talal N, Grey HM, Zvaifler N, Michalski JP, Daniels TE. Elevated salivary and synovial fluid \u03b22-microglobulin in Sjogren\u2019s syndrome and rheumatoid arthritis. Science. 1979;1975(187):1196\u20138.","journal-title":"Science"},{"key":"855_CR154","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1136\/ard.37.4.328","volume":"37","author":"D Manicourt","year":"1978","unstructured":"Manicourt D, Brauman H, Orloff S. Plasma and urinary levels of beta2 microglobulin in rheumatoid arthritis. Ann Rheum Dis. 1978;37:328\u201332.","journal-title":"Ann Rheum Dis"},{"key":"855_CR155","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/03009747809098844","volume":"7","author":"T Str\u00f6m","year":"1978","unstructured":"Str\u00f6m T, Evrin P-E, Karlsson A. Serum beta-2-microglobulin in Sjogren\u2019s Syndrome. Scand J Rheumatol. 1978;7:97\u2013100.","journal-title":"Scand J Rheumatol"},{"key":"855_CR156","first-page":"535","volume":"33","author":"BS Ooi","year":"1977","unstructured":"Ooi BS, Ooi YM, Pesce AI, Pollak VE. Antibodies to \u03b22 microglobulin in the sera of patients with Systemic Lupus Erythematosus. Immunology. 1977;33:535.","journal-title":"Immunology"},{"key":"855_CR157","doi-asserted-by":"publisher","first-page":"614","DOI":"10.4049\/jimmunol.122.2.614","volume":"122","author":"J-P Revillard","year":"1979","unstructured":"Revillard J-P, Vincent C, Rivera S. Anti-\u03b22-microglobulin lymphocytotoxic autoantibodies in Systemic Lupus Erythematosus. J Immunol. 1979;122:614\u20138.","journal-title":"J Immunol"},{"key":"855_CR158","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/art.1780230301","volume":"23","author":"RP Messner","year":"1980","unstructured":"Messner RP, De HR, Ferrone S. Lymphocytotoxic antibodies in systemic lupus erythematosus patients and their relatives. Arthritis Rheumatol. 1980;23:265\u201372.","journal-title":"Arthritis Rheumatol"},{"key":"855_CR159","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/art.1780250403","volume":"25","author":"R Curry","year":"1982","unstructured":"Curry R, Thoen J, Shelborne C, Gaudernack G, Messner R. Antibodies to and elevations of beta 2 microglobulin in the serum of ankylosing spondylitis patients. Arthritis Rheumatol. 1982;25:375\u201380.","journal-title":"Arthritis Rheumatol"},{"key":"855_CR160","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/art.1780190532","volume":"19","author":"M Weissel","year":"1976","unstructured":"Weissel M, Scherak O, Fritzsche H, Kolarz G. Serum \u03b22-microglobulin and SLE. Arthritis Rheumatol. 1976;19:968.","journal-title":"Arthritis Rheumatol"},{"key":"855_CR161","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/rheumatology\/29.6.426","volume":"29","author":"IL McLean","year":"1990","unstructured":"McLean IL, Archer JR, Cawley MID, Pegley FS, Kidd BL, Thompson PW. Specific antibody response to the mycobacterial 65 kDa stress protein in ankylosing spondylitis and rheumatoid arthritis. Rheumatology. 1990;29:426\u20139.","journal-title":"Rheumatology"},{"key":"855_CR162","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jbspin.2011.03.010","volume":"79","author":"N Bodn\u00e1r","year":"2012","unstructured":"Bodn\u00e1r N, Szekanecz Z, Proh\u00e1szka Z, Kem\u00e9ny-Beke \u00c1, N\u00e9methn\u00e9-Gyurcsik Z, Guly\u00e1s K, et al. Anti-mutated citrullinated vimentin (anti-MCV) and anti-65 kDa heat shock protein (anti-hsp65): new biomarkers in ankylosing spondylitis. Joint Bone Spine. 2012;79:63\u20136.","journal-title":"Joint Bone Spine"},{"issue":"Suppl 2","key":"855_CR163","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/annrheumdis-2014-eular.4041","volume":"73","author":"U Kalyoncu","year":"2014","unstructured":"Kalyoncu U, Karadag O, Kilic L, Ertenli I, Bilgen SA, Akdogan A, et al. THU0104 risk factors of advanced spinal disease and\/or bamboo disease in patients with ankylosing sponylitis during TNFI treatments: H\u00dcR-BIO real life results. Ann Rheum Dis. 2014;73(Suppl 2):213.","journal-title":"Ann Rheum Dis"},{"key":"855_CR164","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1242\/jcs.02494","volume":"118","author":"A Clayton","year":"2005","unstructured":"Clayton A, Turkes A, Navabi H, Mason MD, Tabi Z. Induction of heat shock proteins in B-cell exosomes. J Cell Sci. 2005;118:3631\u20138.","journal-title":"J Cell Sci"},{"key":"855_CR165","doi-asserted-by":"publisher","first-page":"23349","DOI":"10.1074\/jbc.M502017200","volume":"280","author":"GI Lancaster","year":"2005","unstructured":"Lancaster GI, Febbraio MA. Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins. J Biol Chem. 2005;280:23349\u201355.","journal-title":"J Biol Chem"},{"key":"855_CR166","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/jcp.21847","volume":"221","author":"C Chavez-Mu\u00f1oz","year":"2009","unstructured":"Chavez-Mu\u00f1oz C, Kilani RT, Ghahary A. Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes. J Cell Physiol. 2009;221:221\u201331. https:\/\/doi.org\/10.1002\/jcp.21847.","journal-title":"J Cell Physiol"},{"key":"855_CR167","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.3899\/jrheum.131446","volume":"41","author":"WP Maksymowych","year":"2014","unstructured":"Maksymowych WP, Naides SJ, Bykerk V, Siminovitch KA, van Schaardenburg D, Boers M, et al. Serum 14-3-3\u03b7 is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis. J Rheumatol. 2014;41:2104\u201313.","journal-title":"J Rheumatol"},{"key":"855_CR168","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/ard.2009.108456","volume":"69","author":"L Damjanovska","year":"2010","unstructured":"Damjanovska L, Thabet MM, Levarth EWN, Stoeken-Rijsbergen G, van der Voort EI, Toes REM, et al. Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis. Ann Rheum Dis. 2010;69:730\u20132.","journal-title":"Ann Rheum Dis"},{"key":"855_CR169","first-page":"920","volume":"31","author":"L Riente","year":"2004","unstructured":"Riente L, Chimenti D, Pratesi F, Delle Sedie A, Tommasi S, Tommasi C, et al. Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis. J Rheumatol. 2004;31:920\u20134.","journal-title":"J Rheumatol"},{"key":"855_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2866","volume":"11","author":"ML Mundwiler","year":"2009","unstructured":"Mundwiler ML, Mei L, Landers CJ, Reveille JD, Targan S, Weisman MH. Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study. Arthritis Res Ther. 2009;11:1\u20137.","journal-title":"Arthritis Res Ther"},{"key":"855_CR171","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1053\/gast.2002.35379","volume":"123","author":"CJ Landers","year":"2002","unstructured":"Landers CJ, Cohavy O, Misra R, Yang H, Lin Y, Braun J, et al. Selected loss of tolerance evidenced by Crohn\u2019s disease\u2013associated immune responses to auto-and microbial antigens. Gastroenterology. 2002;123:689\u201399.","journal-title":"Gastroenterology"},{"key":"855_CR172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4350","volume":"15","author":"D Wallis","year":"2013","unstructured":"Wallis D, Asaduzzaman A, Weisman M, Haroon N, Anton A, McGovern D, et al. Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study. Arthritis Res Ther. 2013;15:1\u20136.","journal-title":"Arthritis Res Ther"},{"key":"855_CR173","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/rheumatology\/kem324","volume":"47","author":"SZ Aydin","year":"2008","unstructured":"Aydin SZ, Atagunduz P, Temel M, Bicakcigil M, Tasan D, Direskeneli H. Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies: a reassessment. Rheumatology. 2008;47:142\u20134.","journal-title":"Rheumatology"},{"key":"855_CR174","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000080081","volume":"70","author":"H-P T\u00f6r\u00f6k","year":"2004","unstructured":"T\u00f6r\u00f6k H-P, Glas J, Gruber R, Brumberger V, Strasser C, Kellner H, et al. Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA. Digestion. 2004;70:49\u201354.","journal-title":"Digestion"},{"key":"855_CR175","doi-asserted-by":"publisher","first-page":"106926","DOI":"10.1016\/j.imlet.2024.106926","volume":"270","author":"M-C Hoffmann","year":"2024","unstructured":"Hoffmann M-C, Fadle N, Regitz E, Kos IA, Cetin O, Lesan V, et al. Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis. Immunol Lett. 2024;270:106926. https:\/\/doi.org\/10.1016\/j.imlet.2024.106926.","journal-title":"Immunol Lett"},{"key":"855_CR176","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.clim.2016.11.006","volume":"174","author":"O-J Iversen","year":"2017","unstructured":"Iversen O-J, Lysvand H, Slupphaug G. Pso p27, a SERPINB3\/B4-derived protein, is most likely a common autoantigen in chronic inflammatory diseases. Clin Immunol. 2017;174:10\u20137.","journal-title":"Clin Immunol"},{"key":"855_CR177","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.3390\/jcm9123968","volume":"9","author":"J-S Lee","year":"2020","unstructured":"Lee J-S, Lee E-J, Lee J-H, Hong S-C, Lee C-K, Yoo B, et al. Autoantibodies against protein phosphatase magnesium-dependent 1A as a biomarker for predicting radiographic progression in ankylosing spondylitis treated with anti-tumor necrosis factor agents. J Clin Med. 2020;9:3968.","journal-title":"J Clin Med"},{"key":"855_CR178","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s00774-020-01176-0","volume":"39","author":"S Tanaka","year":"2021","unstructured":"Tanaka S, Matsumoto T. Sclerostin: from bench to bedside. J Bone Miner Metab. 2021;39:332\u201340.","journal-title":"J Bone Miner Metab"},{"key":"855_CR179","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/annrheumdis-2018-eular.4584","volume":"77","author":"D Benfaremo","year":"2018","unstructured":"Benfaremo D, Luchetti MM, Ciccia F, Avellini C, Spadoni T, Svegliati S, et al. OP0271 Gastrointestinal damage and microbial translocation are involved in the development of immune system activation in inflammatory bowel disease-associated spondyloarthritis. Ann Rheum Dis. 2018;77:184.","journal-title":"Ann Rheum Dis"},{"key":"855_CR180","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.febslet.2009.01.012","volume":"583","author":"H Iioka","year":"2009","unstructured":"Iioka H, Doerner SK, Tamai K. Kaiso is a bimodal modulator for Wnt\/\u03b2-catenin signaling. FEBS Lett. 2009;583:627\u201332.","journal-title":"FEBS Lett"},{"key":"855_CR181","doi-asserted-by":"publisher","first-page":"6143","DOI":"10.1242\/jcs.01541","volume":"117","author":"KF Kelly","year":"2004","unstructured":"Kelly KF, Otchere AA, Graham M, Daniel JM. Nuclear import of the BTB\/POZ transcriptional regulator Kaiso. J Cell Sci. 2004;117:6143\u201352.","journal-title":"J Cell Sci"},{"key":"855_CR182","doi-asserted-by":"publisher","first-page":"e0217220","DOI":"10.1371\/journal.pone.0217220","volume":"14","author":"SC Robinson","year":"2019","unstructured":"Robinson SC, Chaudhary R, Jim\u00e9nez-Saiz R, Rayner LGA, Bayer L, Jordana M, et al. Kaiso-induced intestinal inflammation is preceded by diminished E-cadherin expression and intestinal integrity. PLoS ONE. 2019;14:e0217220.","journal-title":"PLoS ONE"},{"key":"855_CR183","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/art.40490","volume":"70","author":"WK Jubair","year":"2018","unstructured":"Jubair WK, Hendrickson JD, Severs EL, Schulz HM, Adhikari S, Ir D, et al. Modulation of inflammatory arthritis in mice by gut microbiota through mucosal inflammation and autoantibody generation. Arthritis Rheumatol. 2018;70:1220\u201333.","journal-title":"Arthritis Rheumatol"},{"key":"855_CR184","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-3-031-79146-8_12","volume-title":"Oral microbiome: symbiosis, dysbiosis and microbiome interventions for maintaining oral and systemic health","author":"X Yu","year":"2025","unstructured":"Yu X, Mankia K, Do T, Meade J. Oral microbiome dysbiosis and citrullination in rheumatoid arthritis. In: Oral microbiome: symbiosis, dysbiosis and microbiome interventions for maintaining oral and systemic health. 2025. p. 185\u201399."},{"key":"855_CR185","doi-asserted-by":"publisher","first-page":"5192","DOI":"10.3390\/ijms25105192","volume":"25","author":"M-E P\u00e9rez-P\u00e9rez","year":"2024","unstructured":"P\u00e9rez-P\u00e9rez M-E, Nieto-Torres E, Bollain-y-Goytia J-J, Delgadillo-Ru\u00edz L. Protein citrullination by peptidyl arginine deiminase\/arginine deiminase homologs in members of the human microbiota and its recognition by anti-citrullinated protein antibodies. Int J Mol Sci. 2024;25:5192.","journal-title":"Int J Mol Sci"},{"key":"855_CR186","first-page":"59","volume":"43","author":"HC Blenkinsopp","year":"2024","unstructured":"Blenkinsopp HC, Seidler K, Barrow M. Microbial imbalance and intestinal permeability in the pathogenesis of rheumatoid arthritis: a mechanism review with a focus on bacterial translocation, citrullination, and probiotic intervention. J Am Nutr Assoc. 2024;43:59\u201376.","journal-title":"J Am Nutr Assoc"},{"key":"855_CR187","doi-asserted-by":"publisher","first-page":"906258","DOI":"10.3389\/fimmu.2022.906258","volume":"13","author":"WK Mousa","year":"2022","unstructured":"Mousa WK, Chehadeh F, Husband S. Microbial dysbiosis in the gut drives systemic autoimmune diseases. Front Immunol. 2022;13:906258.","journal-title":"Front Immunol"},{"key":"855_CR188","doi-asserted-by":"publisher","first-page":"946248","DOI":"10.3389\/fimmu.2022.946248","volume":"13","author":"A Christovich","year":"2022","unstructured":"Christovich A, Luo XM. Gut microbiota, leaky gut, and autoimmune diseases. Front Immunol. 2022;13:946248.","journal-title":"Front Immunol"},{"key":"855_CR189","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/amh70030036","volume":"70","author":"ECN Lim","year":"2025","unstructured":"Lim ECN, Lim CED. Microbiome-targeted therapies in gastrointestinal diseases: clinical evidence and emerging innovations. Acta Microbiol Hellen. 2025;70:36.","journal-title":"Acta Microbiol Hellen"},{"key":"855_CR190","first-page":"e92881","volume":"17","author":"A Al-Juhani","year":"2025","unstructured":"Al-Juhani A, Desoky MS, Almuhaimid AA, Zaheer M, Alhaqbani HF, Abalkhail EA, et al. Efficacy of gut microbiome-targeted therapies in modulating systemic inflammation and low-grade chronic inflammatory states in adults with metabolic disorders: a systematic review. Cureus. 2025;17:e92881.","journal-title":"Cureus"},{"key":"855_CR191","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1111\/ajt.15753","volume":"20","author":"T Liwinski","year":"2020","unstructured":"Liwinski T, Elinav E. Harnessing the microbiota for therapeutic purposes. Am J Transplant. 2020;20:1482\u20138.","journal-title":"Am J Transplant"},{"key":"855_CR192","doi-asserted-by":"publisher","unstructured":"Clemente JC, Manasson J, Scher JU. The role of the gut microbiome in systemic inflammatory disease. BMJ. 2018;360. https:\/\/doi.org\/10.1136\/bmj.j5145.","DOI":"10.1136\/bmj.j5145"},{"key":"855_CR193","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1080\/17474124.2018.1517044","volume":"12","author":"B Balakrishnan","year":"2018","unstructured":"Balakrishnan B, Taneja V. Microbial modulation of the gut microbiome for treating autoimmune diseases. Expert Rev Gastroenterol Hepatol. 2018;12:985\u201396.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"855_CR194","doi-asserted-by":"publisher","first-page":"396","DOI":"10.5217\/ir.2025.00104","volume":"23","author":"N Rolhion","year":"2025","unstructured":"Rolhion N, Sokol H. Targeting the gut microbiome in inflammatory bowel disease: from concept to clinical reality. Intest Res. 2025;23:396\u2013404.","journal-title":"Intest Res"},{"key":"855_CR195","first-page":"1","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Paz Soldan MM, et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep. 2016;6:1\u201310.","journal-title":"Sci Rep"},{"key":"855_CR196","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3389\/fimmu.2019.00462","volume":"10","author":"SK Shahi","year":"2019","unstructured":"Shahi SK, Freedman SN, Murra AC, Zarei K, Sompallae R, Gibson-Corley KN, et al. Prevotella histicola, a human gut commensal, is as potent as COPAXONE\u00ae in an animal model of multiple sclerosis. Front Immunol. 2019;10:462.","journal-title":"Front Immunol"},{"key":"855_CR197","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.celrep.2017.07.031","volume":"20","author":"A Mangalam","year":"2017","unstructured":"Mangalam A, Shahi SK, Luckey D, Karau M, Marietta E, Luo N, et al. Human gut-derived commensal bacteria suppress CNS inflammatory and demyelinating disease. Cell Rep. 2017;20:1269\u201377.","journal-title":"Cell Rep"},{"key":"855_CR198","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1002\/art.39785","volume":"68","author":"EV Marietta","year":"2016","unstructured":"Marietta EV, Murray JA, Luckey DH, Jeraldo PR, Lamba A, Patel R, et al. Suppression of inflammatory arthritis by human gut-derived Prevotella histicola in humanized mice. Arthritis Rheumatol. 2016;68:2878\u201388.","journal-title":"Arthritis Rheumatol"},{"key":"855_CR199","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.cell.2013.11.024","volume":"155","author":"EY Hsiao","year":"2013","unstructured":"Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155:1451\u201363.","journal-title":"Cell"},{"key":"855_CR200","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/nature07008","volume":"453","author":"SK Mazmanian","year":"2008","unstructured":"Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008;453:620\u20135.","journal-title":"Nature"},{"key":"855_CR201","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.4049\/jimmunol.1001443","volume":"185","author":"J Ochoa-Rep\u00e1raz","year":"2010","unstructured":"Ochoa-Rep\u00e1raz J, Mielcarz DW, Ditrio LE, Burroughs AR, Begum-Haque S, Dasgupta S, et al. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol. 2010;185:4101\u20138.","journal-title":"J Immunol"},{"key":"855_CR202","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cell.2005.05.007","volume":"122","author":"SK Mazmanian","year":"2005","unstructured":"Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005;122:107\u201318.","journal-title":"Cell"},{"key":"855_CR203","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/19490976.2015.1056973","volume":"6","author":"KM Telesford","year":"2015","unstructured":"Telesford KM, Yan W, Ochoa-Reparaz J, Pant A, Kircher C, Christy MA, et al. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39+ Foxp3+ T cells and Treg function. Gut Microbes. 2015;6:234\u201342.","journal-title":"Gut Microbes"},{"key":"855_CR204","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09884-6","volume":"10","author":"C Ramakrishna","year":"2019","unstructured":"Ramakrishna C, Kujawski M, Chu H, Li L, Mazmanian SK, Cantin EM. Bacteroides fragilis polysaccharide A induces IL-10 secreting B and T cells that prevent viral encephalitis. Nat Commun. 2019;10:2153.","journal-title":"Nat Commun"},{"key":"855_CR205","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/03009740310003695","volume":"32","author":"K Hatakka","year":"2003","unstructured":"Hatakka K, Martio J, Korpela M, Herranen M, Poussa T, Laasanen T, et al. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis\u2013a pilot study. Scand J Rheumatol. 2003;32:211\u20135.","journal-title":"Scand J Rheumatol"},{"key":"855_CR206","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.clnu.2016.08.015","volume":"36","author":"E Kouchaki","year":"2017","unstructured":"Kouchaki E, Tamtaji OR, Salami M, Bahmani F, Kakhaki RD, Akbari E, et al. Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2017;36:1245\u20139.","journal-title":"Clin Nutr"},{"key":"855_CR207","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/ana.25244","volume":"83","author":"SK Tankou","year":"2018","unstructured":"Tankou SK, Regev K, Healy BC, Tjon E, Laghi L, Cox LM, et al. A probiotic modulates the microbiome and immunity in multiple sclerosis. Ann Neurol. 2018;83:1147\u201361.","journal-title":"Ann Neurol"},{"key":"855_CR208","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.3899\/jrheum.100193","volume":"37","author":"K Jenks","year":"2010","unstructured":"Jenks K, Stebbings S, Burton J, Schultz M, Herbison P, Highton J. Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial. J Rheumatol. 2010;37:2118\u201325.","journal-title":"J Rheumatol"},{"key":"855_CR209","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.3945\/ajcn.2008.26242","volume":"88","author":"J Vulevic","year":"2008","unstructured":"Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr. 2008;88:1438\u201346.","journal-title":"Am J Clin Nutr"},{"key":"855_CR210","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1017\/S0007114515001889","volume":"114","author":"J Vulevic","year":"2015","unstructured":"Vulevic J, Juric A, Walton GE, Claus SP, Tzortzis G, Toward RE, et al. Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons. Br J Nutr. 2015;114:586\u201395.","journal-title":"Br J Nutr"},{"key":"855_CR211","first-page":"513","volume":"29","author":"J Saavedra","year":"1999","unstructured":"Saavedra J, Tschernia A, Moore N, Abi-Hanna A, Coletta F, Emenhiser C, et al. Gastro-intestinal function in infants consuming a weaning food supplemented with oligofructose, a prebiotic. J Pediatr Gastroenterol Nutr. 1999;29:513.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"855_CR212","first-page":"503","volume":"29","author":"A Tschernia","year":"1999","unstructured":"Tschernia A, Moore N, Abi-Hanna A, Yolken R, Coletta F, Emenhiser C, et al. Effects of long-term consumption of a weaning food supplemented with oligofructose, a prebiotic, on general infant health status. J Pediatr Gastroenterol Nutr. 1999;29:503.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"855_CR213","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1017\/S0007114516000908","volume":"115","author":"ST Clarke","year":"2016","unstructured":"Clarke ST, Green-Johnson JM, Brooks SPJ, Ramdath DD, Bercik P, Avila C, et al. \u03b22-1 fructan supplementation alters host immune responses in a manner consistent with increased exposure to microbial components: results from a double-blinded, randomised, cross-over study in healthy adults. Br J Nutr. 2016;115:1748\u201359.","journal-title":"Br J Nutr"},{"key":"855_CR214","doi-asserted-by":"crossref","unstructured":"Guigoz Y, Rochat F, Perruisseau-Carrier G, Rochat I, Schiffrin EJ. Effects of oligosaccharide on the faecal flora and non-specific immune system in elderly people. 2002;22:13\u201325.","DOI":"10.1016\/S0271-5317(01)00354-2"},{"key":"855_CR215","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/foods8030092","volume":"8","author":"D Davani-Davari","year":"2019","unstructured":"Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, et al. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods. 2019;8:92.","journal-title":"Foods"},{"key":"855_CR216","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/star.201000099","volume":"63","author":"E Fuentes-Zaragoza","year":"2011","unstructured":"Fuentes-Zaragoza E, S\u00e1nchez-Zapata E, Sendra E, Sayas E, Navarro C, Fern\u00e1ndez-L\u00f3pez J, et al. Resistant starch as prebiotic: A review. Starch-St\u00e4rke. 2011;63:406\u201315.","journal-title":"Starch-St\u00e4rke"},{"key":"855_CR217","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/1574-6941.12186","volume":"87","author":"KP Scott","year":"2014","unstructured":"Scott KP, Martin JC, Duncan SH, Flint HJ. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. FEMS Microbiol Ecol. 2014;87:30\u201340.","journal-title":"FEMS Microbiol Ecol"},{"key":"855_CR218","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3945\/ajcn.110.000075","volume":"93","author":"X Tzounis","year":"2011","unstructured":"Tzounis X, Rodriguez-Mateos A, Vulevic J, Gibson GR, Kwik-Uribe C, Spencer JPE. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am J Clin Nutr. 2011;93:62\u201372.","journal-title":"Am J Clin Nutr"},{"key":"855_CR219","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nrgastro.2015.47","volume":"12","author":"LB Bindels","year":"2015","unstructured":"Bindels LB, Delzenne NM, Cani PD, Walter J. Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol. 2015;12:303\u201310.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"855_CR220","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jaci.2010.07.022","volume":"126","author":"C Gr\u00fcber","year":"2010","unstructured":"Gr\u00fcber C, van Stuijvenberg M, Mosca F, Moro G, Chirico G, Braegger CP, et al. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol. 2010;126:791\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"855_CR221","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1136\/adc.2006.098251","volume":"91","author":"G Moro","year":"2006","unstructured":"Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child. 2006;91:814\u20139.","journal-title":"Arch Dis Child"},{"key":"855_CR222","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jaci.2006.09.009","volume":"119","author":"K Kukkonen","year":"2007","unstructured":"Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2007;119:192\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"855_CR223","first-page":"A521","volume":"31","author":"A Firmansyah","year":"2001","unstructured":"Firmansyah A, Pramita G, Carrie Fassler A, Haschke F, Link-Amster H. Improved humoral immune response to measles vaccine in infants receiving infant cereal with fructooligosaccharides. J Pediatr Gastroenterol Nutr. 2001;31:A521.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"855_CR224","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1532-5415.2004.52003.x","volume":"52","author":"B Langkamp-henken","year":"2004","unstructured":"Langkamp-henken B, Bender BS, Gardner EM, Herrlinger-garcia KA, Kelley MJ, Murasko DM, et al. Nutritional formula enhanced immune function and reduced days of symptoms of upper respiratory tract infection in seniors. J Am Geriatr Soc. 2004;52:3\u201312.","journal-title":"J Am Geriatr Soc"},{"key":"855_CR225","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1017\/S0007114511007276","volume":"108","author":"AR Lomax","year":"2012","unstructured":"Lomax AR, Cheung LVY, Tuohy KM, Noakes PS, Miles EA, Calder PC. \u03b22-1 fructans have a bifidogenic effect in healthy middle-aged human subjects but do not alter immune responses examined in the absence of an in vivo immune challenge: results from a randomised controlled trial. Br J Nutr. 2012;108:1818\u201328.","journal-title":"Br J Nutr"},{"key":"855_CR226","doi-asserted-by":"publisher","unstructured":"Zhao N, Wang K, Jiang Y, Huang R. Clinical treatment and clinical application research progress of psoriasis and intestinal microbiota dysbiosis. Clin Cosmet Investig Dermatol. 2025;18:3155\u201364. https:\/\/doi.org\/10.2147\/CCID.S559957.","DOI":"10.2147\/CCID.S559957"},{"key":"855_CR227","doi-asserted-by":"publisher","first-page":"1943289","DOI":"10.1080\/19490976.2021.1943289","volume":"13","author":"LL Blais","year":"2021","unstructured":"Blais LL, Montgomery TL, Amiel E, Deming PB, Krementsov DN. Probiotic and commensal gut microbial therapies in multiple sclerosis and its animal models: a comprehensive review. Gut Microbes. 2021;13:1943289.","journal-title":"Gut Microbes"},{"key":"855_CR228","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-018-0493-6","volume":"26","author":"Y-L Tsai","year":"2019","unstructured":"Tsai Y-L, Lin T-L, Chang C-J, Wu T-R, Lai W-F, Lu C-C, et al. Probiotics, prebiotics and amelioration of diseases. J Biomed Sci. 2019;26:1\u20138.","journal-title":"J Biomed Sci"},{"key":"855_CR229","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/gutjnl-2020-321106","volume":"70","author":"AG Clooney","year":"2021","unstructured":"Clooney AG, Eckenberger J, Laserna-Mendieta E, Sexton KA, Bernstein MT, Vagianos K, et al. Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study. Gut. 2021;70:499\u2013510.","journal-title":"Gut"},{"key":"855_CR230","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.3390\/microorganisms10101963","volume":"10","author":"J Eckenberger","year":"2022","unstructured":"Eckenberger J, Butler JC, Bernstein CN, Shanahan F, Claesson MJ. Interactions between medications and the gut microbiome in inflammatory bowel disease. Microorganisms. 2022;10:1963.","journal-title":"Microorganisms"},{"key":"855_CR231","doi-asserted-by":"crossref","unstructured":"Sinha R, Ahsan H, Blaser M, Caporaso JG, Carmical JR, Chan AT, et al. Next steps in studying the human microbiome and health in prospective studies, Bethesda, MD, May 16\u201317, 2017. 2018.","DOI":"10.1186\/s40168-018-0596-z"},{"key":"855_CR232","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cell.2014.06.037","volume":"158","author":"JK Goodrich","year":"2014","unstructured":"Goodrich JK, Di Rienzi SC, Poole AC, Koren O, Walters WA, Caporaso JG, et al. Conducting a microbiome study. Cell. 2014;158:250\u201362.","journal-title":"Cell"},{"key":"855_CR233","doi-asserted-by":"publisher","unstructured":"Shahi SK, Zarei K, Guseva NV, Mangalam AK. Microbiota analysis using two-step PCR and next-generation 16S rRNA gene sequencing. J Vis Exp. 2019;(152). https:\/\/doi.org\/10.3791\/59980.","DOI":"10.3791\/59980"},{"key":"855_CR234","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581\u20133.","journal-title":"Nat Methods"},{"key":"855_CR235","doi-asserted-by":"publisher","first-page":"fix029","DOI":"10.1093\/femsec\/fix029","volume":"93","author":"M Mysara","year":"2017","unstructured":"Mysara M, Vandamme P, Props R, Kerckhof F-M, Leys N, Boon N, et al. Reconciliation between operational taxonomic units and species boundaries. FEMS Microbiol Ecol. 2017;93:fix029.","journal-title":"FEMS Microbiol Ecol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-026-00855-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00855-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00855-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:03:24Z","timestamp":1781787804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12865-026-00855-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":235,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["855"],"URL":"https:\/\/doi.org\/10.1186\/s12865-026-00855-3","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable\n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable\n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}